Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells
about
Small molecule kinase inhibitors approved by the FDA from 2000 to 2011: a systematic review of preclinical ADME data.Defective posttranslational processing activates the tyrosine kinase encoded by the MET proto-oncogene (hepatocyte growth factor receptor).Ligand-induced stimulation of epidermal growth factor receptor mutants with altered transmembrane regionsCell lines and peripheral blood leukocytes derived from individuals with chronic myelogenous leukemia display virtually identical proteins phosphorylated on tyrosine residuesChronic myelogenous leukemia as a paradigm of early cancer and possible curative strategies.Tyrosine phosphorylation in Myxococcus xanthus, a multicellular prokaryote.Cytogenetic abnormalities in childhood acute lymphoblastic leukemia correlates with clinical features and treatment outcome.A coiled-coil mimetic intercepts BCR-ABL1 dimerization in native and kinase-mutant chronic myeloid leukemiaThe tyrosine kinase encoded by the MET proto-oncogene is activated by autophosphorylationp145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell lineTreatment for chronic myelogenous leukemia: the long road to imatinibReceptor for bombesin with associated tyrosine kinase activity.Activation of tyrosinase kinase and microfilament-binding functions of c-abl by bcr sequences in bcr/abl fusion proteinsA 41-kilodalton protein is a potential substrate for the p210bcr-abl protein-tyrosine kinase in chronic myelogenous leukemia cells.Tumour induction by activated abl involves tyrosine phosphorylation of the product of the cbl oncogene.Protein tyrosine kinases associated with human malignancies.A systematic analysis of physicochemical and ADME properties of all small molecule kinase inhibitors approved by US FDA from January 2001 to October 2015.A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation.A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization.Functional analysis of the ligand binding site of EGF-receptor utilizing chimeric chicken/human receptor molecules.A tyrosine protein kinase activated by bombesin in normal fibroblasts and small cell carcinomas.Demonstration that LSTRA cells have an elevated level of proteins phosphorylated on tyrosine residues.Proteins phosphorylated on tyrosine as markers of human tumor cell lines
P2860
Q30664269-416E7B0D-9B79-4FDE-8E2D-E56902B1DA1FQ33238614-2ECEE0E3-B521-40DF-B167-968133D56098Q33685781-CAD154E7-290C-4526-81C1-7481746D475CQ34634185-926EFB66-7207-4005-A6C1-267463EFC550Q35166848-4B77B152-81FE-49E4-AA94-70BBA52F54D9Q35609415-70EAFE92-BBBE-41D6-9BBD-2CC3EC4D6227Q35664675-7E8A8D33-D169-4B8B-ADE7-386D7B5CD938Q36210636-BA048B0B-F7E2-4642-8447-136184976A0CQ36687206-A48FF027-9AC0-4F93-862A-5B256C46A7CBQ36793873-FBC2CA93-8396-43E6-9C6E-783F34E4FE0FQ36900105-8E1DF726-8934-4A16-AF60-569DDA088B37Q36902393-D7275F86-60AB-488E-8242-B19D17605714Q36959846-96D344A8-3CB8-4C17-BA6D-1A49B65FC4FAQ36963802-487F1B1D-8B5B-43FB-9B7B-039A3BCB28B7Q37636620-83E1DFDD-206A-4AFF-BEF7-12CE2586FB10Q38185391-F6DB73D3-3542-4652-8540-7EC6248DFE36Q38763312-974653F3-065A-49CE-9040-E13D1B4487BDQ40608574-561CDA32-89AB-4B97-A403-E805937776F9Q40677644-BD376BAF-F165-4BE8-80C1-9C4476FD1946Q40817131-04E7BB7C-432E-4D59-8669-2CBD25473F9DQ41338454-32533B68-7EB2-45D0-807C-57564C342F76Q45771458-D902D7E4-BDE7-4BC7-B28A-55DECAA8B6B4Q58165830-CA519816-00F6-46A8-8F73-B486EF386A2B
P2860
Phosphotyrosine antibodies identify the p210c-abl tyrosine kinase and proteins phosphorylated on tyrosine in human chronic myelogenous leukemia cells
description
1986 nî lūn-bûn
@nan
1986年の論文
@ja
1986年論文
@yue
1986年論文
@zh-hant
1986年論文
@zh-hk
1986年論文
@zh-mo
1986年論文
@zh-tw
1986年论文
@wuu
1986年论文
@zh
1986年论文
@zh-cn
name
Phosphotyrosine antibodies ide ...... nic myelogenous leukemia cells
@en
type
label
Phosphotyrosine antibodies ide ...... nic myelogenous leukemia cells
@en
prefLabel
Phosphotyrosine antibodies ide ...... nic myelogenous leukemia cells
@en
P2093
P2860
P356
P1476
Phosphotyrosine antibodies ide ...... nic myelogenous leukemia cells
@en
P2093
A Stacchini
D M Cirillo
P M Comoglio
P2860
P304
P356
10.1128/MCB.6.5.1803
P407
P577
1986-05-01T00:00:00Z